成人中枢神经细胞瘤:不同年龄组的临床特征与长期治疗结局
连续纳入80例成人中枢神经细胞瘤患者,平均发病年龄28.4±7.6岁(范围19-66岁),比较年轻组(<27岁)与年长组(≥27岁)的临床特征和长期治疗结局。年轻组更常表现为多症状、颅内压增高症状、急性病程、术前神经功能更差及病灶更大;发病年龄较大或≥27岁及显微术后KPS恶化与长期结局未改善相关。手术可阻止神经功能恶化并获得满意结局。
要点
- 年轻组(<27岁)较年长组(≥27岁)更易表现为多症状和颅内压增高症状(P=0.002和P=0.036)。
- 发病年龄较大(P=0.005)或年龄≥27岁(P=0.014)及术后即刻KPS恶化(P=0.040)与长期结局未改善相关。
- 手术可阻止神经功能恶化并确保满意结局。
核心结论
- 年轻成人中枢神经细胞瘤的临床表现与年长组不同,手术可阻止神经功能恶化并获得满意结局。
研究设计与样本
- 连续纳入80例成人中枢神经细胞瘤患者,平均发病年龄28.4±7.6岁(范围19-66岁),比较年轻组(<27岁,30例,37.5%)与年长组(≥27岁)的临床特征和长期治疗结局。
主要发现
- 年轻组(<27岁)较年长组(≥27岁)更常表现为多症状(P=0.002)、颅内压增高症状(P=0.036)、急性临床病程(P=0.037)、术前神经功能更差(P=0.023)及病灶更大(大小P=0.004,体积P=0.007)。
- 发病年龄较大(P=0.005)或年龄≥27岁(P=0.014)及显微术后即刻KPS恶化(P=0.040)与长期结局未改善相关。
临床怎么用
- 手术可阻止神经功能恶化并确保满意结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Central neurocytomas (CNs) usually occur in young adults, and the clinical characteristics and surgical outcomes of patients in different age groups may be different. METHODS: This study was undertaken to compare the clinical and long-term treatment outcomes of patients with CNs in younger and older adult age groups. RESULTS: Eighty consecutive adults with CNs were included, with a mean presentation age of 28.4±7.6 years (range: 19-66 years). Thirty (37.5%) patients were <27 years old, and they tended to manifest with multiple symptoms (P = 0.002), increased intracranial pressure (ICP) symptoms (P = 0.036), an acute clinical course (P = 0.037), worse preoperative neurologic function (P = 0.023), and a larger lesion size and volume (P = 0.004 and 0.007, respectively) than their older age counterparts (≧27 years). An older onset age (P = 0.005) or age ≧27 years (P = 0.014) and worsened Karnofsky Performance Status (KPS) scale (P = 0.040) immediately after microsurgery were associated with unimproved long-term outcomes. CONCLUSIONS: CNs in younger adult patients behave differently from those in the older age group. Surgery can halt neurologic deterioration and ensure satisfactory outcomes.
引用
- Zhang L, Xue J, Liu A, et al. Adult Central Neurocytomas: Clinical Features and Long-Term Treatment Outcomes in Different Age Groups. World Neurosurg. 2024. PMID: 38604535. doi:10.1016/j.wneu.2024.04.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。